IMPAIRED RENAL FUNCTION AND ANEMIA IN PATIENTS WITH CHRONIC HEART FAILURE

Authors

  • Khusainova Munira Alisherovna Author

Keywords:

Key words: chronic heart failure, kidney disease, anemia, microalbuminuria, N- acetyl–β-dexosaminidase.

Abstract

Chronic heart failure (CHF) accompanies most cardiovascular diseases and is 
their outcome, remaining unchanged One of the main reasons for the high level of 
disability  and  mortality  of  patients.  Increasing  heart  failure  over  time  exceeds  the 
danger to the patient's life of the disease that caused heart failure.  Renal function has 
a great influence on the prognosis and outcome of CHF. Kidney failure is considered 
as a factor, determining the survival rate of patients with left ventricular dysfunction. 
Currently, the diagnosis of renal dysfunction in patients with CHF is based on the 
determination  of  concentration  Serum  creatinine  levels,  glomerular  filtration  rate 
(GFR) and/or the presence of microalbuminuria (MAU) or macroalbuminuria. At the 
same time, the issue of tubule function and the daily profile of renal function (daily 
filtration rate) in patients with CHF remains insufficiently studied. Anemia associated 
with CHF continues to attract the attention of researchers. This is the purpose of this 
work.  

References

1. Ibragimov, K., Sultonov, I., & Ravshanova, M. (2024). The Effectiveness of the

Combination Therapy with biologic DMARDS in Rheumatoid Arthritis. Frontiers

of Global Science, 2(1), 17-24.

2. Ziyadullaev, S. K., Sultonov, I. I., Dushanova, G. A., & Akbarovna, K. S. (2021).

The Effectiveness Of Pharmacotherapy For Dmards With Ra Depending On The

C3435t Polymorphism Of The Mdr1 Gene. Int. J. of Aquatic Science, 12(3), 2908-

2916.

3. Sobirov, A., & Sultonov, I. (2024). COMPREHENSIVE ANALYSIS OF

CLINICAL NEUROPSYCHOLOGICAL AND NEUROIMAGING ASPECTS OF

ALZHEIMER'S DISEASE. Frontiers of Global Science, 2(1).

4. Islomovich, S. I., Alisherovna, K. M., & Djamshedovna, K. D. (2024). FACTORS

OF OSTEOPOROSIS IN PATIENTS WITH CORONARY HEART DISEASE IN

COMBINATION WITH RHEUMATOID ARTHRITIS. Ta'lim innovatsiyasi va

integratsiyasi, 31(2), 132-138.

5. Islomovich, S. I. (2024). GENDER CHARACTERISTICS OF THE CURRENT

RHEUMATOID ARTHRITIS. International journal of medical sciences, 4(10), 3-

8.

6. Islomovich, S. I. (2024). FEATURES OF THE COURSE OF PREGNANCY IN

RHEUMATOID ARTHRITIS. International journal of medical sciences, 4(10),

77-84.

7. Djamshedovna, K. D., Alisherovna, K. M., & Islomovich, S. I. (2024). ARTERIAL

HYPERTENSION IN RHEUMATOID ARTHRITIS. Ta'lim innovatsiyasi va

integratsiyasi, 31(2), 139-145.

8. Alisherovna, K. M., Nizamitdinovich, K. S., & Islomovich, S. I. (2024). THERAPY

OF RHEUMATOID ARTHRITIS DURING PREGNANCYTHE. Ta'lim

innovatsiyasi va integratsiyasi, 31(2), 172-180.

9. Nizamitdinovich, K. S., Alisherovna, K. M., & Islomovich, S. I. (2024). CLINICAL

COURSE OF BRONCHIAL ASTHMA IN PATIENTS WITH THYROID

DISEASES. Ta'lim innovatsiyasi va integratsiyasi, 31(2), 181-187.

10. Alisherovna, K. M., Islomovich, S. I., & Djamshedovna, K. D. (2024).

PSYCHOEMOTIONAL STATE AND QUALITY OF LIFE IN PATIENTS WITH

SYSTEMIC LUPUS ERYTHEMATOSUS. Ta'lim innovatsiyasi va

integratsiyasi, 31(2), 124-131.

11. Ilkhom, S. (2023). CAJAM–VOLUME 1. ISSUE 1. 2023. Central Asian Journal

of Advanced Medicine, 1(01), 16-19.

12. Alisherovna, K. M., Nizamitdinovich, K. S., & Islomovich, S. I. (2024).

FEATURES OF BONE MINERAL DENSITY IN PATIENTS WITH DISEASES

OF THE DIGESTIVE SYSTEM. Ta'lim innovatsiyasi va integratsiyasi, 31(2),

162-171.

13. Хамраева, Н. А., Султонов, И. И., & Хасанов, Ф. Ш. У. (2019). Кожные

проявления у больных системной красной волчанкой. Вопросы науки и

образования, (28 (77)), 128-131.

14. Sultonov, I. I., Kh, Z. S., Ruzybakieva, M. R., Kireev, V. V., Aripova, T. U., &

Suyarov, A. A. (2021). Pharmacogenetic Aspects of Drug Resistance in

Rheumatoid Arthritis. Annals of the Romanian Society for Cell Biology, 4147-4150.

15. Тоиров, А. Э., Султонов, И. И., & Тоиров, Э. С. (2020). ЗНАЧЕНИЕ

ДИСФУНКЦИИ ПОЧЕК У БОЛЬНЫХ ОСТРЫМ ИНФАРКТОМ

МИОКАРДА НА ФОНЕ САХАРНОГО ДИАБЕТА 2-ГО ТИПА. Вестник

науки и образования, (9-3 (87)), 86-91.

16. Kireev, V. V., & Sultonov, I. I. (2021). Genetic Engineered Preparations-An

Innovative Approach in the Treatment of Rheumatoid Arthritis. Annals of the

Romanian Society for Cell Biology, 4114-4119.

17. Hamraeva, N. A., Sultonov, I. I., & Hasanov, F. S. (2020). Systemic lupus

erythematosus treatment strategy. Journal of Critical Reviews, 7(9), 269-270.

18. Иргашева, У. З., Султонов, И. И., & Тоиров, Д. Р. (2013). Признаки дебюта

системной красной волчанки. Академический журнал Западной Сибири, 9(1),

15-15.

19. Xasanov, F. S., & Sultonov, I. I. (2023). RHEUMATOID ARTHRITIS TREATED

WITH DMARDS AND CARDIOVASCULAR DISEASE RISK. Oriental Journal

of Medicine and Pharmacology, 3(02), 45-52.

20. Sultonov, I. I., Xasanov, F. S., Eshmuratov, S., Uralov, R. S., Shukurova, D., &

Ziyadullayev, S. X. Predictors of Systemic Lupus Erythematosus: A Case-control

Study. International journal of health sciences, 6(S10), 175-182.

21. Khusainova, M. A. (2023). CYSTATIN C IS AN EARLY MARKER OF

DECREASED KIDNEY FUNCTION. Oriental renaissance: Innovative,

educational, natural and social sciences, 3(1), 485-490.

22. Khusainova, M. A. (2023). Comorbidity thyrotoxicosis with coronary heart

disease. Science and Education, 4(5), 205-213.

23. Khusainova, M. A., Eshmamatova, F. B., Ismoilova, K. T., & Mamadiyorova, M.

M. (2023). METABOLIC SYNDROME IN RHEUMATOID ARTHRITIS AS A

CRITERION OF CARDIOVASCULAR RISK. Oriental renaissance: Innovative,

educational, natural and social sciences, 3(1), 331-339.

24. Khusainova, M. A., Vakhidov, J. J., Khayitov, S. M., & Mamadiyorova, M. M.

(2023). Cardiac arrhythmias in patients with rheumatoid arthritis. Science and

Education, 4(2), 130-137.

25. Khusainova, M. A., Khaydarov, S. N., Uzokov, J. B., & Karabayeva, G. K. (2023).

KIDNEY CONDITION IN PATIENTS WITH CHRONIC HEART

FAILURE. Oriental renaissance: Innovative, educational, natural and social

sciences, 3(2), 102-112.

26. Khusainova, M. A., Khaydarov, S. N., Makhmudova, K. D., & Nayimov, A. S.

(2023). Prevalence of bronchiolitis in patients with Rheumatoid arthritis. Science

and Education, 4(5), 232-241.

27. Khusainova, M. A., Ergashova, M. M., Eshmamatova, F. B., & Khayitov, S. M.

(2023). Features of quality of life indicators in patients with pneumonia. Science

and Education, 4(2), 138-144.

28. Khusainova, M. A., Khaydarov, S. N., Makhmudova, K. D., & Ortikova, S. X.

(2023). Features of prevention of chronic kidney diseases and chronic heart

failure. Science and Education, 4(5), 242-250.

29. Khusainova, M. A., Khaydarov, S. N., Uzokov, J. B., & Shonazarova, N. K. (2023).

QUALITY OF LIFE IN PATIENTS WITH CHOLELITHIASIS IN THE LONG-TERM PERIOD AFTER CHOLECYSTECTOMY. Oriental renaissance:

Innovative, educational, natural and social sciences, 3(2), 231-239.

30. Khaydarov, S. N., Khusainova, M. A., Uzokov, J. B., & Makhmudova, K. D.

(2023). Heart failure and the risk of hypoglycemia. Science and Education, 4(5),

222-231.

31. Khusainova, M. A., & Yarmatov, S. T. (2021). CARDIAC ARRHYTHMIAS AND

CARDIOHEMODYNAMIC DISORDERS IN PATIENTS VIRAL CIRRHOSIS

OF THE LIVER. Scientific progress, 2(2), 196-202.

32. Yarmatov, S., Khusainova, M., & Djabbarova, N. (2023). STUDY OF QUALITY

OF LIFE INDICATORS IN PATIENTS WITH CORONARY HEART DISEASE

USING THE SF-36 QUESTIONNAIRE. Бюллетень студентов нового

Узбекистана, 1(7), 58-64.

33. Alisherovna, K. M., Erkinovna, S. D., Duskobilovich, B. S., & Samandarovich, T.

H. (2024). ARTERIAL HYPERTENSION IN THYROTOXICOSIS AND

REMODELING OF THE LEFT VENTRICLE OF THE HEART. Ta'lim

innovatsiyasi va integratsiyasi, 19(4), 114-121.

34. Alisherovna, K. M., Erkinovna, S. D., Yazdonkulovna, X. M., & Zafarovna, C. M.

M. (2024). ATRIAL FIBRILLATION IN THYROTOXICOSIS–

DETERMINANTS OF DEVELOPMENT AND CONSERVATION. Ta'lim

innovatsiyasi va integratsiyasi, 19(4), 103-113.

35. Alisherovna, K. M., Yaxshiboyevich, U. M. R., & Yigitaliyevich, B. A. (2024).

EVALUATION OF A NATRIURETIC PEPTIDE TO OPTIMIZE THE

MANAGEMENT OF COMORBID PATIENTS WITH THYROTOXICOSIS

AND HEART FAILURE. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 62-70.

36. Alisherovna, K. M., Habibulloyevna, I. M., & Voxidovna, R. F. (2024).

STRUCTURAL AND FUNCTIONAL FEATURES OF THE LEFT VENTRICLE

IN PATIENTS WITH HEART FAILUREIN ISCHEMIC HEART DISEASE AND

THYROTOXICOSIS. Ta'lim innovatsiyasi va integratsiyasi, 19(4), 71-81.

37. Alisherovna, K. M., Toshtemirovna, E. M. M., Duskobilovich, B. S., &

Umirxanovna, K. G. (2022). DYSFUNCTION LEFT VENTRICULAR IN

BRONCHIAL ASTHMA. Spectrum Journal of Innovation, Reforms and

Development, 4, 216-221.

38. Alisherovna, K. M., Kulmuxammatovich, Y. U., Boymamatovna, E. F., &

Shokirovich, S. A. (2023). THE STATE OF NEUROPEPTIDE-CYTOKINE

STATUS IN ISCHEMIC HEART DISEASE. Spectrum Journal of Innovation,

Reforms and Development, 11, 42-50.

Published

2025-02-11

How to Cite

Khusainova Munira Alisherovna. (2025). IMPAIRED RENAL FUNCTION AND ANEMIA IN PATIENTS WITH CHRONIC HEART FAILURE . Ta’lim Innovatsiyasi Va Integratsiyasi, 39(1), 131-138. https://journal-web.uz/index.php/06/article/view/1120

Similar Articles

1-10 of 27

You may also start an advanced similarity search for this article.